• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Lancet Pen Needles Market Analysis

    ID: MRFR/MED/0112-CR
    145 Pages
    Kinjoll Dey
    July 2019

    Lancet And Pen Needles Market Trends And Growth Analysis By Type (Lancet {Regular Lancets And Safety Lancets} [Push Button Safety Lancet, Pressure Activated Safety Lancet And Side Button Safety Lancet] And Pen Needles {Standard Needles And Safety Needles}), By Application (Insulin, Capillary Blood Sampling, Hormones, Glucose Like Peptide (Glp), Skin Testing And Others) By End User (Hospitals &a...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Lancet Pen Needles Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Market Analysis

    In-depth Analysis of Lancet Pen Needles Market Industry Landscape

    The global safety lancet market is currently experiencing significant transformations, prompting a reevaluation of the effectiveness of existing regulatory frameworks for medical devices in both developed and developing regions. The ongoing discussions and initiatives underscore the need for robust regulatory measures that ensure the performance, quality, and safety of medical devices. The aim is to enhance and refine medical device regulations to uphold public and patient health, ensuring the delivery of effective technologies and high-quality products to patients. The dynamic landscape of the safety lancet market has introduced a variety of medical devices, each presenting unique regulatory challenges. These challenges are influenced by the increasing number and complexity of medical devices, leading to a more intricate regulatory environment. Medical devices are generally classified into three types—Type I, Type II, and Type III—based on their complexity of use and the associated risks. The regulatory framework imposes stringent standards on safety lancets, necessitating continuous monitoring and improvement in terms of quality, performance, and safety. This stringent oversight is designed to provide patients with assurance regarding the reliability and safety of approved medical devices, ultimately contributing to an increase in the credibility and demand for these devices in the market. The evolving regulatory landscape is a response to the mounting complexities and diversification in medical devices, particularly safety lancets. The classification into different types reflects the varying levels of intricacy and risk associated with their use. Type I devices typically pose the lowest risk, while Type III devices, characterized by higher complexity, carry a higher level of risk. This tiered classification ensures that regulatory measures are tailored to address the specific challenges and nuances associated with each type of medical device. As the regulatory environment becomes more stringent, manufacturers and stakeholders in the safety lancet market are compelled to adhere to rigorous standards, resulting in continuous improvements in the design, production, and overall quality of these devices. This commitment to quality assurance not only safeguards patient well-being but also elevates the credibility of approved medical devices in the competitive market landscape. The ongoing transformations in the global safety lancet market highlight the imperative need for enhanced regulatory frameworks that prioritize the safety, quality, and performance of medical devices. The stringent oversight, particularly in the classification of medical devices into distinct types, is instrumental in addressing the diverse challenges posed by the evolving landscape of healthcare technology. Through these regulatory measures, the safety lancet market aims to uphold the highest standards, ensuring that patients have access to reliable and safe medical devices that meet the stringent criteria set by regulatory authorities.

    Market Summary

    As per Market Research Future Analysis, the Lancet and Pen Needles Market was valued at USD 2.9 Billion in 2023 and is projected to grow from USD 3.23 Billion in 2024 to USD 5.34 Billion by 2032, with a CAGR of 11.34% during the forecast period (2024 - 2032). The market is driven by the increasing prevalence of diabetes and blood-borne diseases, alongside a growing preference for home healthcare. Technological advancements are leading to the development of innovative and safer devices, enhancing patient safety and care. The market is highly competitive, with significant investments in research and development by key players.

    Key Market Trends & Highlights

    The Lancet and Pen Needles Market is experiencing rapid growth driven by several key factors.

    • Market Size in 2023: USD 2.9 Billion.
    • Projected Market Size by 2032: USD 5.34 Billion.
    • CAGR from 2024 to 2032: 11.34%.
    • Highest Market Share Region: European Union.

    Market Size & Forecast

    2023 Market Size USD 2.9 Billion
    2024 Market Size USD 3.23 Billion
    2032 Market Size USD 5.34 Billion
    CAGR (2024-2032) 11.34%
    Expected Market Size by 2027 USD 9,789.63 Million.

    Major Players

    Abbott Laboratories, Terumo Corporation, Beacon Dickinson, Sanofi, F. Hoffmann-LaRoche, Bayer A.G., Novo Nordisk A.S., Eli Lily and company, Owen Mumford LTD, Medtronic.

    Market Trends

    The increasing prevalence of diabetes and other chronic conditions is driving the demand for advanced pen needles and lancets, suggesting a shift towards more user-friendly and efficient diabetes management solutions.

    Centers for Disease Control and Prevention (CDC)

    Lancet Pen Needles Market Market Drivers

    Market Growth Projections

    The Global Lancet and Pen Needles Market Industry is poised for substantial growth over the coming years. Projections indicate that the market will expand from a value of 3.23 USD Billion in 2024 to approximately 7.37 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate of 7.79% from 2025 to 2035, driven by factors such as rising diabetes prevalence, technological advancements, and increasing awareness of self-monitoring. The market's expansion reflects the critical role that lancets and pen needles play in effective diabetes management on a global scale.

    Rising Prevalence of Diabetes

    The increasing prevalence of diabetes globally serves as a primary driver for the Global Lancet and Pen Needles Market Industry. As of 2024, the number of individuals diagnosed with diabetes is projected to reach approximately 537 million, necessitating effective management solutions. This surge in diabetes cases fuels demand for pen needles and lancets, which are essential for insulin delivery and blood glucose monitoring. The market is expected to grow significantly, with projections indicating a value of 3.23 USD Billion in 2024, reflecting the urgent need for reliable and user-friendly devices in diabetes care.

    Increasing Geriatric Population

    The increasing geriatric population worldwide is another critical factor influencing the Global Lancet and Pen Needles Market Industry. Older adults are more susceptible to chronic conditions such as diabetes, necessitating regular monitoring and management. As the global population aged 65 and above continues to grow, the demand for user-friendly and efficient diabetes management tools, including lancets and pen needles, is expected to rise. This demographic shift is likely to contribute to the market's expansion, as healthcare systems adapt to meet the needs of an aging population requiring effective diabetes care solutions.

    Regulatory Support and Initiatives

    Regulatory support and initiatives aimed at improving diabetes care are pivotal in shaping the Global Lancet and Pen Needles Market Industry. Governments and health organizations are increasingly recognizing the importance of accessible diabetes management tools, leading to favorable policies and funding for research and development. Such initiatives not only enhance the availability of innovative devices but also promote their adoption among healthcare providers and patients. This supportive regulatory environment is likely to facilitate market growth, ensuring that effective and safe lancets and pen needles are readily available to those in need.

    Growing Awareness of Self-Monitoring

    There is a growing awareness regarding self-monitoring of blood glucose levels among patients, which significantly drives the Global Lancet and Pen Needles Market Industry. Educational initiatives and campaigns by health organizations have led to increased patient engagement in managing their health. This trend encourages individuals to utilize pen needles and lancets for effective self-monitoring, thereby enhancing treatment adherence. As a result, the market is projected to experience a compound annual growth rate of 7.79% from 2025 to 2035, reflecting the rising demand for self-monitoring devices in diabetes care.

    Technological Advancements in Devices

    Technological advancements in lancets and pen needles are transforming the Global Lancet and Pen Needles Market Industry. Innovations such as safety-engineered devices and smart pen technology enhance user experience and safety. These developments not only improve the accuracy of blood sampling and insulin delivery but also reduce the risk of needlestick injuries. As healthcare providers and patients increasingly adopt these advanced devices, the market is likely to witness substantial growth. By 2035, the market could reach an estimated value of 7.37 USD Billion, driven by the continuous evolution of technology in diabetes management.

    Market Segment Insights

    Regional Insights

    Key Companies in the Lancet Pen Needles Market market include

    Industry Developments

      • Braun Melsungen set up an office in Zambia in 2017
      • Sanofi and Lonza set up a partnership to produce large-scale biologics in Switzerland
      • Eli Lily and Rimini set up a partnership to develop customized insulin medicines

    Future Outlook

    Lancet Pen Needles Market Future Outlook

    The Lancet and Pen Needles Market is projected to grow at a 7.79% CAGR from 2024 to 2035, driven by technological advancements, increasing diabetes prevalence, and rising healthcare expenditure.

    New opportunities lie in:

    • Develop smart pen needles with integrated technology for enhanced patient adherence.
    • Expand product lines to include eco-friendly, biodegradable lancets.
    • Leverage telehealth platforms to offer remote monitoring solutions with lancets and pen needles.

    By 2035, the market is expected to exhibit robust growth, reflecting advancements and increased demand.

    Market Segmentation

    Lancet and Pen Needles Market Segmentation

    Key Players in the Lancet and Pen Needles Market
    • Terumo Corporation - Japan
    • Beacon Dickinson - USA
    • Sanofi - USA
    • F. Hoffmann-LaRoche - Switzerland
    • Bayer A.G. - Germany
    • Novo Nordisk A.S. - USA
    • Eli Lily and company - USA
    • Owen Mumford LTD - USA
    • Medtronic - USA
    • Greiner Bio-one - USA
    • Abbott laboratories - USA
    • HTL - Strefa SA - USA
    • Improve medical - the USA

    Report Scope

    Attribute/Metric Details
    Market Size 2023 2.9 (USD Billion)
    Market Size 2024 3.23 (USD Billion)
    Market Size 2032 5.34 (USD Billion)
    Compound Annual Growth Rate (CAGR) 11.34 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
    Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
    Key Vendors Terumo Corporation - Japan Beacon Dickinson - USA Sanofi - USA F. Hoffmann-LaRoche - Switzerland Bayer A.G. - Germany Novo Nordisk A.S. - USA Eli Lily and company - USA Owen Mumford LTD - USA Medtronic - USA Greiner Bio-one - USA Abbott laboratories - USA HTL - Strefa SA - USA Improve medical - the USA
    Key Market Opportunities Healthcare providers are also able to provide these patients with better healthcare.
    Key Market Drivers There are two things that are driving fast growth in the lancet and pen needles market. 

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    At what CAGR is the global lancet and pen needles market projected to grow in the forecast period (2024-2032)?

    lancet and pen needles market projected to grow at approximately 11.34% CAGR during the assessment period (2024-2032).

    How much is the global lancet and pen needles market worth in the future?

    The valuation of the global lancet and pen needles market is estimated to increase to USD 5.34 Billion by the end of 2032.

    What are the major tailwinds pushing the growth of the global lancet and pen needles market?

    Increasing prevalence of diabetes & blood-borne diseases and improving medical device regulations worldwide are major tailwinds pushing the growth of the global lancet and pen needles market.

    Which region holds the largest share in the global lancet and pen needles market?

    Europe holds the largest share in the global lancet and pen needles market, followed by North America and the Asia Pacific, respectively.

    Who are the top players in the global lancet and pen needles market?

    Terumo Corporation, B. Braun Melsungen AG, Becton Dickinson, F. Hoffmann-La Roche AG, Sanofi, Bayer AG, Eli Lilly and Company, Novo Nordisk A S, Owen Mumford Ltd, Ypsomed Holding AG, Medtronic, Sarstedt AG & Co, Abbott Laboratories, Greiner Bio One, HTL-STREFA S.A, UltiMed, Inc., Improve Medical, Allison Medical, Inc., VOGT MEDICAL, Artsana S.p.a., Perrigo Diabetes Care, ARKRAY Inc., MedExel Co., Ltd, Simple Diagnostics, Trividia Health, and Stat Medical, Terumo, are some of the top players operating in the global lancet and pen needles market.

    1. Report Prologue
      1. Increasing Awareness Of Lancet And Pen Needles: 15
      2. Production Of Lancet And Pen Needles: 15
      3. FDA Regulation For Lancet: 16
    2. Market Introduction
      1. Introduction 19
      2. Scope Of Study 19
      3. Research Objective 19
      4. Assumptions & Limitations 20
        1. Assumptions 20
        2. Limitations 20
      5. Market Structure 21
    3. Research Methodology
      1. Research Process 22
      2. Primary Research 23
      3. Secondary Research 23
      4. Market Size Estimation 23
    4. Market Dynamics
      1. Introduction 25
      2. Drivers 26
        1. Increasing Prevalence Of Diabetes 26
        2. Growing Incidence Number Of Contagious And Non-Contagious Diseases 27
        3. Increasing Inclination Towards Home Healthcare 28
        4. Improving Medical Device Regulation 29
      3. Restraints 30
        1. Risk Associated With Blood Transfusion 30
        2. Growing Adoption Of Oral Drug Delivery Systems, Reuse Of Pen Needles And Infusion Sets 31
      4. Opportunities 32
      5. Mega Trends: 32
      6. Macroeconomic Indicators 33
    5. Market Factor Analysis
      1. Porter’s Five Forces Model 34
        1. Bargaining Power Of Suppliers 35
        2. Bargaining Power Of Buyers 35
        3. Threat Of New Entrants 35
        4. Threat Of Substitutes 35
        5. Intensity Of Rivalry 35
      2. Value Chain Analysis 36
        1. R&D 36
        2. Manufacturing 36
        3. Distribution & Sales 37
        4. Post-Sales Monitoring 37
      3. Demand & Supply: Gap Analysis 37
      4. Pricing Analysis 37
      5. Investment Opportunity Analysis 38
    6. Lancet And Pen Needles Market, By Type
      1. Lancet 40
        1. Regular Lancet 40
        2. Safety Lancet 40
      2. Pen Needles 42
        1. Standard Needles 42
        2. Safety Needles 43
    7. Lancet And Pen Needles Market, By Application
      1. Insulin 45
      2. Capillary Blood Sampling 46
      3. Hormones 47
      4. Glucose Like Peptide (GLP) 47
      5. Skin Testing 48
    8. Lancet And Pen Needles Market, By End User
      1. Hospitals & Clinics 50
      2. Diagnostic Centers & Medical Institutions 51
      3. Home Care & Home Diagnostics 52
      4. Research & Academic Laboratories 53
    9.  
    10. Global Lancet And Pen Needles Market, By Region
      1. Introduction 54
      2. Europe 56
    11. Lancet And Pen Needles Market, By Type
    12. Lancet And Pen Needles Market, By Application
    13. Lancet And Pen Needles Market, By End User
      1. Western Europe 59
    14. Lancet And Pen Needles Market, By Type
    15. Lancet And Pen Needles Market, By Application
    16. Lancet And Pen Needles Market, By End User
      1. Germany 61
    17. Lancet And Pen Needles Market, By Application
    18. Lancet And Pen Needles Market, By End User
      1. France 64
        1. U.K 66
    19. Lancet And Pen Needles Market, By Type
      1. Italy 69
    20. Lancet And Pen Needles Market, By Application
      1. SPAIN 71
    21. Lancet And Pen Needles Market, By End User
      1. Rest Of Western Europe 74
        1. Eastern Europe 76
      2. Americas 80
        1. North America 83
    22. Lancet And Pen Needles Market, By Type
      1. U.S. 85
        1. Canada 88
        2. South America 90
      2. Asia Pacific 94
        1. Japan 97
        2. China 99
    23. Lancet And Pen Needles Market, By Type
      1. India 102
        1. South Korea 104
    24. Lancet And Pen Needles Market, By Application
    25. Lancet And Pen Needles Market, By End User
      1. Australia 107
        1. Rest Of Asia Pacific 109
      2. The Middle East & Africa 113
        1. UAE 116
    26. Lancet And Pen Needles Market, By Type
      1. Saudi Arabia 118
    27. Lancet And Pen Needles Market, By Application
    28. Lancet And Pen Needles Market, By End User
      1. Kuwait 121
    29. Lancet And Pen Needles Market, By End User
      1. Qatar 123
        1. Africa 126
    30. Competitive Landscape
      1. Introduction 129
      2. Company Share Analysis 129
    31. Company Profile
      1. B. Braun Melsungen AG 131
        1. Company Overview 131
        2. Financials 131
        3. Products 131
        4. Strategy 131
        5. Key Developments 131
      2. Terumo Corporation 132
        1. Company Overview 132
        2. Financials 132
        3. Products 132
        4. Strategy 132
        5. Key Developments 132
      3. Becton Dickinson 133
        1. Company Overview 133
        2. Financials 133
        3. Products 133
        4. Strategy 133
        5. Key Developments 133
      4. Sanofi 134
        1. Company Overview 134
        2. Financials 134
        3. Products 134
        4. Strategy 134
        5. Key Developments 134
      5. F. Hoffmann-La Roche AG 135
        1. Company Overview 135
        2. Financials 135
        3. Products 135
        4. Strategy 135
        5. Key Developments 135
      6. Bayer AG 136
        1. Company Overview 136
        2. Financials 136
        3. Products 136
        4. Strategy 136
        5. Key Developments 136
      7. Novo Nordisk A S 137
        1. Company Overview 137
        2. Financials 137
        3. Products 137
        4. Strategy 137
        5. Key Developments 137
      8. Eli Lilly And Company 138
        1. Company Overview 138
        2. Financials 138
        3. Products 138
        4. Strategy 138
        5. Key Developments 138
      9. Owen Mumford Ltd 139
        1. Company Overview 139
        2. Financials 139
        3. Products 139
        4. Strategy 139
        5. Key Developments 139
      10. Medtronic 140
        1. Company Overview 140
        2. Financials 140
        3. Products 140
        4. Strategy 140
        5. Key Developments 140
      11. Ypsomed Holding AG 141
        1. Company Overview 141
        2. Financials 141
        3. Products 141
        4. Strategy 141
        5. Key Developments 141
      12. Sarstedt AG & Co 142
        1. Company Overview 142
        2. Financials 142
        3. Products 142
        4. Strategy 142
        5. Key Developments 142
      13. Greiner Bio One 143
        1. Company Overview 143
        2. Financials 143
        3. Products 143
        4. Strategy 143
        5. Key Developments 143
      14. Abbott Laboratories 144
        1. Company Overview 144
        2. Financials 144
        3. Products 144
        4. Strategy 144
        5. Key Developments 144
      15. HTL-STREFA S.A. 145
        1. Company Overview 145
        2. Financials 145
        3. Products 145
        4. Strategy 145
        5. Key Developments 145
      16. Improve Medical 146
        1. Company Overview 146
        2. Financials 146
        3. Products 146
        4. Strategy 146
        5. Key Developments 146
    32. MRFR Conclusion
      1. Key Findings 147
        1. From CEO’s View Point 147
        2. Unmet Needs Of The Market 147
      2. Key Companies To Watch 148
      3. Prediction Of Lancet And Pen Needles Industry 148
    33. Appendix
      1. Discussion Blue Print 149
    34. List of Tables and Figures
      1. 14 List Of Tables
      2. TABLE 1 GLOBAL LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 39
      3. TABLE 2 GLOBAL LANCET AND PEN NEEDLES MARKET, BY LANCET, 2022-2030 (USD MILLION) 40
      4. TABLE 3 GLOBAL LANCET AND PEN NEEDLES MARKET, BY PEN NEEDLES, 2022-2030 (USD MILLION) 42
      5. TABLE 4 GLOBAL LANCET AND PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 44
      6. TABLE 5 GLOBAL LANCET AND PEN NEEDLES MARKET, BY INSULIN, 2022-2030 (USD MILLION) 46
      7. TABLE 6 GLOBAL LANCET AND PEN NEEDLES MARKET, BY CAPILLARY BLOOD SAMPLING, 2022-2030 (USD MILLION) 46
      8. TABLE 7 GLOBAL LANCET AND PEN NEEDLES MARKET, BY HORMONES, 2022-2030 (USD MILLION) 47
      9. TABLE 8 GLOBAL LANCET AND PEN NEEDLES MARKET, BY GLUCOSE LIKE PEPTIDE (GLP), 2022-2030 (USD MILLION) 47
      10. TABLE 9 GLOBAL LANCET AND PEN NEEDLES MARKET, BY SKIN TESTING, 2022-2030 (USD MILLION) 48
      11. TABLE 10 GLOBAL LANCET AND PEN NEEDLES MARKET, BY END USER, 2022-2030 (USD MILLION) 49
      12. TABLE 11 GLOBAL LANCET AND PEN NEEDLES MARKET BY HOSPITALS & CLINICS, 2022-2030 (USD MILLION) 51
      13. TABLE 12 GLOBAL LANCET AND PEN NEEDLES MARKET BY DIAGNOSTIC CENTERS & MEDICAL INSTITUTIONS, 2022-2030 (USD MILLION) 51
      14. TABLE 13 GLOBAL LANCET AND PEN NEEDLES MARKET BY HOME CARE & HOME DIAGNOSTICS, 2022-2030 (USD MILLION) 52
      15. TABLE 14 GLOBAL LANCET AND PEN NEEDLES MARKET BY RESEARCH & ACADEMIC LABORATORIES, 2022-2030 (USD MILLION) 53
      16. TABLE 15 EUROPE LANCET AND PEN NEEDLES MARKET, BY COUNTRY, 2022- 2030 (USD MILLION) 56
      17. TABLE 16 EUROPE LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 56
      18. TABLE 17 EUROPE LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 57
      19. TABLE 18 EUROPE SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 57
      20. TABLE 19 EUROPE PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 57
      21. TABLE 20 EUROPE APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 58
      22. TABLE 21 EUROPE END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 58
      23. TABLE 22 WESTERN EUROPE LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 59
      24. TABLE 23 WESTERN EUROPE LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 59
      25. TABLE 24 WESTERN EUROPE SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 59
      26. TABLE 25 WESTERN EUROPE PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 60
      27. TABLE 26 WESTERN EUROPE APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 60
      28. TABLE 27 WESTERN EUROPE END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 61
      29. TABLE 28 GERMANY LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 61
      30. TABLE 29 GERMANY LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 62
      31. TABLE 30 GERMANY SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 62
      32. TABLE 31 GERMANY PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 62
      33. TABLE 32 GERMANY APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 63
      34. TABLE 33 GERMANY END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 63
      35. TABLE 34 FRANCE LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 64
      36. TABLE 35 FRANCE LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 64
      37. TABLE 36 FRANCE SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 64
      38. TABLE 37 FRANCE PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 65
      39. TABLE 38 FRANCE APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 65
      40. TABLE 39 FRANCE END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 66
      41. TABLE 40 U.K LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 66
      42. TABLE 41 U.K LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 67
      43. TABLE 42 U.K SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 67
      44. TABLE 43 U.K PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 67
      45. TABLE 44 U.K APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 68
      46. TABLE 45 U.K END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 68
      47. TABLE 46 ITALY LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 69
      48. TABLE 47 ITALY LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 69
      49. TABLE 48 ITALY SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 69
      50. TABLE 49 ITALY PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 70
      51. TABLE 50 ITALY APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 70
      52. TABLE 51 ITALY END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 71
      53. TABLE 52 SPAIN LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 71
      54. TABLE 53 SPAIN LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 72
      55. TABLE 54 SPAIN SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 72
      56. TABLE 55 SPAIN PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 72
      57. TABLE 56 SPAIN APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 73
      58. TABLE 57 SPAIN END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 73
      59. TABLE 58 REST OF WESTERN EUROPE LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 74
      60. TABLE 59 REST OF WESTERN EUROPE LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 74
      61. TABLE 60 REST OF WESTERN EUROPE SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 74
      62. TABLE 61 REST OF WESTERN EUROPE PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 75
      63. TABLE 62 REST OF WESTERN EUROPE APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 75
      64. TABLE 63 REST OF WESTERN EUROPE END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 76
      65. TABLE 64 EASTERN EUROPE LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 76
      66. TABLE 65 EASTERN EUROPE LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 77
      67. TABLE 66 EASTERN EUROPE SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 77
      68. TABLE 67 EASTERN EUROPE PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 77
      69. TABLE 68 EASTERN EUROPE APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 78
      70. TABLE 69 EASTERN EUROPE END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 78
      71. TABLE 70 AMERICAS LANCET AND PEN NEEDLES MARKET, BY REGION, 2022- 2030 (USD MILLION) 80
      72. TABLE 71 AMERICAS LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 80
      73. TABLE 72 AMERICAS LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 80
      74. TABLE 73 AMERICAS SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 81
      75. TABLE 74 AMERICAS PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 81
      76. TABLE 75 AMERICAS APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 82
      77. TABLE 76 AMERICAS END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 82
      78. TABLE 77 NORTH AMERICA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 83
      79. TABLE 78 NORTH AMERICA LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 83
      80. TABLE 79 NORTH AMERICA SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 83
      81. TABLE 80 NORTH AMERICA PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 84
      82. TABLE 81 NORTH AMERICA APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 84
      83. TABLE 82 NORTH AMERICA END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 85
      84. TABLE 83 U.S. LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 85
      85. TABLE 84 U.S. LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 86
      86. TABLE 85 U.S. SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 86
      87. TABLE 86 U.S. PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 86
      88. TABLE 87 U.S. APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 87
      89. TABLE 88 U.S. END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 87
      90. TABLE 89 CANADA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 88
      91. TABLE 90 CANADA LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 88
      92. TABLE 91 CANADA SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 88
      93. TABLE 92 CANADA PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 89
      94. TABLE 93 CANADA APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 89
      95. TABLE 94 CANADA END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 90
      96. TABLE 95 SOUTH AMERICA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 90
      97. TABLE 96 OUTH AMERICA LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 91
      98. TABLE 97 SOUTH AMERICA SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 91
      99. TABLE 98 SOUTH AMERICA PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 91
      100. TABLE 99 SOUTH AMERICA APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 92
      101. TABLE 100 SOUTH AMERICA END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 92
      102. TABLE 101 ASIA PACIFIC LANCET AND PEN NEEDLES MARKET, BY COUNTRY, 2022- 2030 (USD MILLION) 94
      103. TABLE 102 ASIA PACIFIC LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 94
      104. TABLE 103 ASIA PACIFIC LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 95
      105. TABLE 104 ASIA PACIFIC SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 95
      106. TABLE 105 ASIA PACIFIC PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 95
      107. TABLE 106 ASIA PACIFIC APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 96
      108. TABLE 107 ASIA PACIFIC END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 96
      109. TABLE 108 JAPAN LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 97
      110. TABLE 109 JAPAN LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 97
      111. TABLE 110 JAPAN SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 97
      112. TABLE 111 JAPAN PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 98
      113. TABLE 112 JAPAN APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 98
      114. TABLE 113 JAPAN END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 99
      115. TABLE 114 CHINA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 99
      116. TABLE 115 CHINA LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 100
      117. TABLE 116 CHINA SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 100
      118. TABLE 117 CHINA PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 100
      119. TABLE 118 CHINA APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 101
      120. TABLE 119 CHINA END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 101
      121. TABLE 120 INDIA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 102
      122. TABLE 121 INDIA LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 102
      123. TABLE 122 INDIA SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 102
      124. TABLE 123 INDIA PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 103
      125. TABLE 124 INDIA APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 103
      126. TABLE 125 INDIA END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 104
      127. TABLE 126 SOUTH KOREA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 104
      128. TABLE 127 SOUTH KOREA LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 105
      129. TABLE 128 SOUTH KOREA SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 105
      130. TABLE 129 SOUTH KOREA PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 105
      131. TABLE 130 SOUTH KOREA APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 106
      132. TABLE 131 SOUTH KOREA END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 106
      133. TABLE 132 AUSTRALIA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 107
      134. TABLE 133 AUSTRALIA LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 107
      135. TABLE 134 AUSTRALIA SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 107
      136. TABLE 135 AUSTRALIA PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 108
      137. TABLE 136 AUSTRALIA APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 108
      138. TABLE 137 AUSTRALIA END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 109
      139. TABLE 138 REST OF ASIA PACIFIC LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 109
      140. TABLE 139 REST OF ASIA PACIFIC LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 110
      141. TABLE 140 REST OF ASIA PACIFIC SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 110
      142. TABLE 141 REST OF ASIA PACIFIC PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 110
      143. TABLE 142 REST OF ASIA PACIFIC APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 111
      144. TABLE 143 REST OF ASIA PACIFIC END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 111
      145. TABLE 144 THE MIDDLE EAST & AFRICA LANCET AND PEN NEEDLES MARKET, BY COUNTRY, 2022- 2030 (USD MILLION) 113
      146. TABLE 145 THE MIDDLE EAST & AFRICA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 113
      147. TABLE 146 THE MIDDLE EAST & AFRICA LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 114
      148. TABLE 147 THE MIDDLE EAST & AFRICA SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 114
      149. TABLE 148 THE MIDDLE EAST & AFRICA PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 114
      150. TABLE 149 THE MIDDLE EAST & AFRICA APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 115
      151. TABLE 150 THE MIDDLE EAST & AFRICA END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 115
      152. TABLE 151 UAE LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 116
      153. TABLE 152 UAE LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 116
      154. TABLE 153 UAE SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 116
      155. TABLE 154 UAE PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 117
      156. TABLE 155 UAE APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 117
      157. TABLE 156 UAE END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 118
      158. TABLE 157 SAUDI ARABIA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 118
      159. TABLE 158 SAUDI ARABIA LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 119
      160. TABLE 159 SAUDI ARABIA SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 119
      161. TABLE 160 SAUDI ARABIA PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 119
      162. TABLE 161 SAUDI ARABIA APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 120
      163. TABLE 162 SAUDI ARABIA END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 120
      164. TABLE 163 KUWAIT LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 121
      165. TABLE 164 KUWAIT LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 121
      166. TABLE 165 KUWAIT SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 121
      167. TABLE 166 KUWAIT PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 122
      168. TABLE 167 KUWAIT APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 122
      169. TABLE 168 KUWAIT END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 123
      170. TABLE 169 QATAR LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 123
      171. TABLE 170 QATAR LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 124
      172. TABLE 171 QATAR SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 124
      173. TABLE 172 QATAR PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 124
      174. TABLE 173 QATAR APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 125
      175. TABLE 174 QATAR END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 125
      176. TABLE 175 AFRICA LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 126
      177. TABLE 176 AFRICA LANCETS MARKET, BY TYPE, 2022-2030 (USD MILLION) 126
      178. TABLE 177 AFRICA SAFETY MARKET, BY TYPE, 2022-2030 (USD MILLION) 126
      179. TABLE 178 AFRICA PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION) 127
      180. TABLE 179 AFRICA APPLICATION MARKET, BY TYPE, 2022-2030 (USD MILLION) 127
      181. TABLE 180 AFRICA END USER MARKET, BY TYPE, 2022-2030 (USD MILLION) 128 15 List Of Figures
      182. FIGURE 1 GLOBAL LANCET AND PEN NEEDLES MARKET, BY TYPE, 2022 (%) 16
      183. FIGURE 2 GLOBAL LANCET AND PEN NEEDLES MARKET, BY APPLICATION, 2022 (%) 17
      184. FIGURE 3 GLOBAL LANCET AND PEN NEEDLES MARKET, BY END USER, 2022 (%) 17
      185. FIGURE 4 GLOBAL LANCETS AND PEN NEEDLES MARKET, BY REGION, 2022 (%) 18
      186. FIGURE 5 GLOBAL LANCET AND PEN NEEDLES MARKET: MARKET STRUCTURE 21
      187. FIGURE 6 RESEARCH PROCESS 22
      188. FIGURE 7 PORTERS FIVE FORCES MODEL: GLOBAL LANCET AND PEN NEEDLES MARKET 34
      189. FIGURE 8 GLOBAL LANCET AND PEN NEEDLES MARKET, BY END USER, 2022 & 2030 (USD MILLION) 39
      190. FIGURE 9 GLOBAL LANCET AND PEN NEEDLES MARKET, BY APPLICATION, 2022 & 2030 (USD MILLION) 45
      191. FIGURE 10 GLOBAL LANCET AND PEN NEEDLES MARKET, BY END USER, 2022 & 2030 (USD MILLION) 50
      192. FIGURE 11 GLOBAL LANCET AND PEN NEEDLES MARKET: COMPANY SHARE ANALYSIS, 2022 (%) 130

    Lancet and Pen Needles Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027